Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Stock Market
Government
Executive Activities
Banking
Corporate Performance
Economic News
International and US Foreign Trade
Aerospace & Defense
Commodities & Futures
Table bottom

Hematology
Sae-A Trading Co., Ltd (Sae-A), a leading global apparel manufacturer and exporter with 11,000 employees in Haiti, led its fifth medical mission to Northern Haiti. The mission provides free medical care to local residents in the communities...
PR Newswire, 9:08am ET



-- ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian cancer, regardless of BRCA mutation or biomarker status -- Approval supported by robust data from a randomized, well-controlled Phase 3 trial...
GlobeNewswire, 7:08am ET

- ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian cancer, regardless of BRCA mutation or biomarker status - Approval supported by robust data from a randomized, well-controlled Phase 3 trial...
Globe Newswire, 7:08am ET

Novartis International AG / Novartis drug Tasigna(R) (nilotinib) secures EU approval for first and second-line treatment of Ph+ CML-CP in children . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for...
Globe Newswire, 1:23am ET

1-4 of 4


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.